The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 05, 2014

Filed:

May. 12, 2010
Applicants:

Dov Tamarkin, Maccabim, IL;

Doron Friedman, Karmei Yosef, IL;

Enbal Ziv, Gedera, IL;

Meir Eini, Ness Ziona, IL;

Tal Berman, Rishom Lezion, IL;

Jorge Danziger, Rishom Lezion, IL;

Rita Keynan, Rehovot, IL;

David Schuz, Moshav Gimzu, IL;

Inventors:

Dov Tamarkin, Maccabim, IL;

Doron Friedman, Karmei Yosef, IL;

Enbal Ziv, Gedera, IL;

Meir Eini, Ness Ziona, IL;

Tal Berman, Rishom Lezion, IL;

Jorge Danziger, Rishom Lezion, IL;

Rita Keynan, Rehovot, IL;

David Schuz, Moshav Gimzu, IL;

Assignee:

Foamix Ltd., Rehovot, IL;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61Q 19/00 (2006.01); A61K 9/12 (2006.01); A61K 9/00 (2006.01); A61K 47/06 (2006.01); A61K 8/04 (2006.01); A61K 8/31 (2006.01); A61K 9/107 (2006.01);
U.S. Cl.
CPC ...
A61K 8/046 (2013.01); A61K 9/122 (2013.01); A61K 2800/31 (2013.01); A61K 9/107 (2013.01); A61K 9/0014 (2013.01); A61K 47/06 (2013.01); A61Q 19/00 (2013.01); A61K 8/31 (2013.01); Y10S 514/859 (2013.01);
Abstract

The present invention relates to stable substantially non-aqueous, non-alcoholic, non-silicone, foamable carrier compositions comprising petrolatum or mixtures thereof, at least one foam agent, at least one propellant, and with and without the addition of an active agent. The formulations may contain a solvent substantially miscible therein. The present invention further provides a method of treating, alleviating or preventing a disorder of mammalian subject in need thereof, comprising administering the above-mentioned compositions to an afflicted target site of said mammalian subject.


Find Patent Forward Citations

Loading…